Delcath Systems Inc. (DCTH) Hits New 1-Year Low at $3.32
Shares of Delcath Systems Inc. (NASDAQ:DCTH) reached a new 52-week low on Tuesday . The company traded as low as $3.32 and last traded at $3.34, with a volume of 21,159 shares. The stock had previously closed at $3.51.
The stock’s market cap is $4.72 million. The firm has a 50 day moving average price of $4.03 and a 200-day moving average price of $4.81.
Delcath Systems (NASDAQ:DCTH) last announced its earnings results on Wednesday, May 4th. The medical device company reported ($0.08) EPS for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.11. On average, equities research analysts forecast that Delcath Systems Inc. will post ($7.84) earnings per share for the current fiscal year.
Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.